title: Bull's eye maculopathy in an HIV-positive patient receiving ritonavir.
abstract: Retinal toxicity involving the macula as a complication of the antiretroviral protease inhibitor ritonavir has been described in a few cases. We report retinal pigment epitheliopathy involving the macula with a bull's eye pattern in a 36-year-old man with well-controlled HIV receiving ritonavir with gradually progressive bilateral vision loss.
authors.affiliation: Division of Infectious Diseases, Washington University School of Medicine, St Louis, MO, USA. lnon@dom.wustl.edu.
authors.forename: Lemuel
authors.initials: L
authors.lastname: Non
authors.forename: Abdallah
authors.initials: A
authors.lastname: Jeroudi
authors.forename: Bradley T
authors.initials: BT
authors.lastname: Smith
authors.forename: Shadi
authors.initials: S
authors.lastname: Parsaei
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008268:Macular Degeneration / Q000139:chemically induced*; D008297:Male; D019438:Ritonavir / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D019438:Ritonavir